Cellular Plasticity, Metabolic Adaptations and Therapeutic Strategies in Breast Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: 30 July 2026 | Viewed by 31
Special Issue Editor
2. Cancer Center and Research Institute, University of Mississippi Medical Center, Jackson, MS, USA
Interests: cancer biology; breast cancer; ovarian cancer; transcription; biomarkers; therapy resistance; cellular plasticity
Special Issue Information
Dear Colleagues,
Breast cancer represents a diverse group of diseases, shaped by underlying genetic, molecular, and cellular heterogeneity. Tumor plasticity and metabolic reprogramming allow cancer cells to adapt, persist, and ultimately drive disease progression even in the face of therapy. For early-stage breast cancer, surgery and radiotherapy remain the cornerstone treatments, often complemented by endocrine therapy for hormone receptor–positive disease and anti-HER2 agents for tumors overexpressing HER2. Chemotherapy is still widely used, especially in higher-risk or triple-negative cases. In advanced settings, treatment has evolved to include CDK4/6 inhibitors and, for those with BRCA mutations, PARP inhibitors. Antibody–drug conjugates and immunotherapy, particularly for select subgroups like PD-L1-positive triple-negative breast cancer, are offering new hope. Despite progress, therapy resistance and relapse, often driven by dynamic phenotypic switching and metabolic adaptation, underscore the urgent need for precision strategies that target these adaptive states and prevent escape mechanisms.
We are pleased to invite you to contribute your valuable work to this Special Issue on “Cellular Plasticity, Metabolic Adaptations and Therapeutic Strategies in Breast Cancer”.
This Special Issue aims to collect papers focused on recent advances in the diagnosis, mechanisms, and treatment of breast cancer with an emphasis on plasticity-driven and metabolism-linked vulnerabilities.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:
- Diagnosis and biomarkers: metabolic and plasticity biomarkers, liquid biopsy, multi-omics, single-cell/spatial profiling, functional imaging;
- Mechanisms of plasticity: EMT/MET dynamics, cancer stem cells, lineage/state transitions, epigenetic regulation of phenotype;
- Metabolic reprogramming: glycolysis and oxidative metabolism, lipid and one-carbon metabolism, redox balance, mitochondrial pathways;
- Tumor microenvironment: stromal–immune crosstalk, hypoxia/nutrient stress, extracellular vesicles and metabolic signaling;
- Therapeutic strategies: metabolism-targeted agents, differentiation/plasticity-modulating therapies, rational combinations with endocrine, anti-HER2, CDK4/6, PARP, ADCs, and immunotherapy;
- Resistance and translational studies: mechanisms of primary/acquired resistance, predictive signatures, biomarker-guided trials and real-world evidence.
We look forward to receiving your contributions.
Dr. Kunwar Somesh Vikramdeo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- cellular plasticity
- metabolic reprogramming
- tumor microenvironment
- therapy resistance
- epithelial–mesenchymal transition (EMT)
- cancer stem cells
- redox metabolism
- mitochondrial pathways
- targeted therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
